Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Adult Immunization Programs in Nontraditional Settings: Quality Standards and Guidance for Program Evaluation

A Report of the National Vaccine Advisory Committee

National Vaccine Advisory Committee Membership List

CHAIRMAN
Georges Peter, M.D.
Brown University School of Medicine
Providence, Rhode Island

ACTING EXECUTIVE SECRETARY
Martin Meyers, M.D.
National Vaccine Program Office, CDC
Atlanta, Georgia

PAST CHAIRMAN
Edgar Marcuse, M.D., M.P.H.
University of Washington
Seattle, Washington

PAST EXECUTIVE SECRETARY
Robert Breiman, M.D.
National Vaccine Program Office, CDC
Atlanta, Georgia

MEMBERS

Michael Decker, M.D., M.P.H.
Vanderbilt University School of Medicine
Nashville, Tennessee

Mary des Vignes-Kendrick, M.D.
City of Houston
Department of Health and Human Services
Houston, Texas

Theodore Eickhoff, M.D.
University of Colorado Health Sciences Center
Denver, Colorado

Amy Fine, M.P.H.
Washington, D.C.

Virginia Galvin, M.D.
Cobb/Douglas Health District
Marietta, Georgia

Jerome Klein, M.D.
Boston University School of Medicine
Boston, Massachusetts

F. Marc LaForce, M.D.
BASICS 2
Arlington, Virginia

Myron Levine, M.D.
University of Maryland School of Medicine
Baltimore, Maryland

Yvonne Maldonado, M.D.
Stanford University School of Medicine
Stanford, California

Thomas Monath, M.D.
OraVax, Incorporated
Cambridge, Massachusetts

June Osborn, M.D.
Josiah Macy, Jr. Foundation
New York, New York

Peter Paradiso, Ph.D.
Wyeth-Lederle Vaccines and Pediatrics
West Henrietta, New York

Stanley Plotkin, M.D.
Aventis Pasteur
Doylestown, Pennsylvania

Gregory Poland, M.D.
Mayo Clinic and Foundation
Rochester, Minnesota

Patricia Quinlisk, M.D.
Iowa Department of Public Health
Des Moines, Iowa

David Smith, M.D.
Texas Tech University
Lubbock, Texas

Marian Sokol, Ph.D.
Any Baby Can, Inc.
San Antonio, Texas

Daniel Soland
SmithKline Beecham Pharmaceuticals
Belgium

Patricia Whitley-Williams, M.D.
University of Medicine and Dentistry/Robert Wood Johnson Medical School
New Brunswick, New Jersey

Donald Williamson, M.D.
Alabama Department of Public Health
Montgomery, Alabama

EX OFFICIO MEMBERS

David Benor, J.D.
Office of General Counsel
Rockville, Maryland

William Egan, Ph.D.
Food and Drug Administration
Rockville, Maryland

Col. Renata Engler, M.D.
Department of Defense/Walter Reed Medical Center
Washington, D.C.

Geoffrey Evans, M.D.
Health Resources and Services Administration
Rockville, Maryland

Ruth Frischer, Ph.D.
Agency for International Development
Washington, D.C.

T. Randolph Graydon
Health Care Financing Administration
Baltimore, Maryland

John LaMontagne, Ph.D.
National Institutes of Health
Bethesda, Maryland

Walter Orenstein, M.D.
CDC
Atlanta, Georgia

J.P. Passino, M.P.H.
Department of Agriculture
Alexandria, Virginia

William Robinson, M.D.
Health Resources and Services Administration
Rockville, Maryland

LIAISON REPRESENTATIVES

James Foy, D.O.
American Association of Health Plans
Columbus, Ohio

Mary Glode, M.D.
Advisory Committee for Immunization Practices
Denver, Colorado

Adele Young, Ph.D., P.N.P.
Advisory Commission on Childhood Vaccines
Fairfax, Virginia

WORKSHOP PARTICIPANTS

American Academy of Nurse Practitioners

American Academy of Family Physicians

American Academy of Pediatrics

American Association of Occupational Health Nurses

American Association of Retired Persons

American College of Nurse Midwives

American College of Physicians

American Dental Association

American Health Care Association

American Medical Association

American Nurses Association/Foundation

American Osteopathic Association

American Pharmaceutical Association

Association of State and Territorial Dental Directors

Association of State and Territorial Health Officials

Aventis Pasteur

North American Vaccine

Clinical Directors Network

Council of State and Territorial Epidemiologists

CVS/Pharmacy

Delmarva Foundation

Food and Drug Administration

Georgia Drug and Narcotics Agency/Georgia State Board of Pharmacy

Health Care Financing Administration

Health Resources and Services Administration

Immunization Education and Action Committee, National Healthy Mothers, Healthy Babies Coalition

International Health Corporation

Little Havana Activities and Nutrition Centers of Dade County, Inc.

Merck & Company, Inc. 

Mississippi Board of Pharmacy

Mollen Immunization Clinics

National Association of Boards of Pharmacy

National Association of Childbearing Centers Foundation/Maternity Center Association

National Association of Community Health Centers

National Black Nurses Association

National Center for Infectious Diseases, CDC

National Coalition for Adult Immunization

National Coalition of Hispanic Health and Human Services

National Council of La Raza

National Council on the Aging, Inc.

National Immunization Program, CDC

National Institute for Allergy and Infectious Diseases National Institutes of Health

National Medical Association

Office of Minority Health, CDC

SmithKline Beecham Pharmaceuticals

Virginia State Health Department

Visiting Nurses Association of America

Wyeth-Ayerst 

 

The following CDC staff members prepared this report:

Alicia S. Postema, M.P.H.
Robert F. Breiman, M.D.
National Vaccine Program Office
Office of the Director

 

Adult Immunization Programs in Nontraditional Settings: Quality Standards and Guidance for Program Evaluation

A Report of the National Vaccine Advisory Committee

Summary

This report provides a summary of the National Vaccine Advisory Committee's (NVAC) workshop on adult immunization programs in nontraditional settings, quality standards for such programs, and guidance for program evaluation. Throughout the United States, an increasing number of adults are receiving vaccine in nontraditional settings (e.g., pharmacies and churches). Immunization programs in nontraditional settings are often more accessible and convenient than a health-care provider's office or a public health clinic, especially for medically underserved adults (e.g., economically disadvantaged, inner city, and minority populations). Medically underserved adults might be at particular risk for undervaccination because they are often without a medical home (i.e., a regular point of contact where their health-care needs are met). Immunization programs in nontraditional settings might enhance the capacity of the health-care system to effectively deliver vaccine to adults by increasing the number and types of sites where adults can receive vaccine. NVAC has recognized that strategies need to be developed to make vaccines available to all adults and that the number of immunization programs in nontraditional settings is increasing. Therefore, the Committee issues the following report, including quality standards and guidance for program evaluation.

BACKGROUND

Approximately 45,000 adults in the United States die annually of complications from influenza, pneumococcal infections, and hepatitis B -- the primary vaccine-preventable diseases affecting adults. The total economic cost of treating these vaccine-preventable diseases among adults, excluding the value of years of life lost, exceeds $10 billion each year. Although effective vaccines to prevent these diseases are available, they are widely underutilized (1,2). This underutilization reflects a lack of emphasis on vaccines for adults in comparison with the more substantial emphasis on vaccines for children.

Influenza and pneumococcal vaccine coverage rates for adults aged >65 years vary by race and ethnicity (2). In 1997, influenza vaccine coverage rates ranged from 67.2% among non-Hispanic whites to 50.2% among non-Hispanic blacks (2). Pneumococcal vaccine coverage rates were even lower: 47.3% of white adults aged >65 years reported receiving pneumococcal vaccine compared with 34.1% of Hispanics and 29.7% of blacks (2). Disease burden also varies by race and ethnicity. Blacks have a threefold to fivefold increased risk for developing life-threatening invasive pneumococcal disease compared with whites (3-5). 

A recommendation by a health-care provider is a key factor determining whether an adult patient will be vaccinated (6). Medically underserved adults (e.g., economically disadvantaged, inner city, and minority populations) might be at particular risk for underimmunization because they are often without a medical home (i.e., a regular point of contact where their health-care needs are met) and might not have regular access to a health-care provider (7-10). Therefore, to reach medically underserved adults, strategies to increase vaccine-seeking behavior are critically needed. One such strategy involves offering vaccine to adults in nontraditional settings (e.g., pharmacies and churches) that might be more accessible and convenient than the office of a health-care provider or a public health clinic. Immunization programs in nontraditional settings might enhance the capacity of the health-care system to effectively deliver vaccine to adults by increasing the number and types of settings in which adults can receive vaccine.

INTRODUCTION

Purpose of the National Vaccine Advisory Committee Workshop

The National Vaccine Program Office sponsored a public meeting of the National Vaccine Advisory Committee's (NVAC) Adult Immunization Working Group on December 1-2, 1997, to explore adult immunization programs in nontraditional settings. The purpose of the workshop was

  • to gain a better understanding of programs currently offering vaccines to adults in nontraditional settings,
  • to identify potential benefits and challenges associated with administering vaccines in nontraditional settings,
  • to identify additional nontraditional settings that could be explored and potentially used,
  • to define areas where additional research is needed,
  • to develop an effective immunization strategy integrating immunization programs in nontraditional settings with those in traditional settings, and
  • to develop quality standards for immunization programs in nontraditional settings.

The workshop was limited to discussion regarding vaccines for adults because national vaccine coverage estimates for adults are substantially lower than the national goals established for this population, whereas coverage estimates for children approach or exceed national goals (2,7,11).

The purpose of this report is to provide a summary of discussions at the NVAC workshop so that persons who conduct or plan to conduct immunization programs in a nontraditional setting will have guidance regarding how to safely operate such a program. This report also highlights the importance of evaluating these programs by collecting data regarding associated benefits (e.g., increases in the number of adults vaccinated) and challenges (e.g., preventing fragmentation of care by reporting administration of vaccine to the primary-care provider of the vaccinee).

Influenza and pneumococcal vaccines constitute the majority of vaccines administered in nontraditional settings; therefore, this report focuses on these vaccines. If the types of vaccines administered in nontraditional settings increase, both the benefits and challenges could change.

Workshop Participants

Workshop participants included members of the NVAC Adult Immunization Working Group and representatives from approximately 50 organizations, including federal and state governments, community and professional organizations, and private companies. Participants were identified through discussions with staff at CDC, the Health Resources and Services Administration, the National Coalition for Adult Immunization (NCAI), and other organizations. NCAI is composed of nearly 100 professional medical and health-care associations, advocacy groups, voluntary organizations, vaccine manufacturers, and government agencies. Workshop presenters were selected to ensure that a spectrum of viewpoints was represented.

SUMMARY OF WORKSHOP PRESENTATIONS

Information regarding the U.S. Department of Health and Human Services' Adult Immunization Action Plan (1), vaccine coverage rates, and incidence of morbidity and mortality attributable to vaccine-preventable diseases among adults was presented. The American College of Physicians (ACP) and the National Medical Association provided physicians' perspectives of administration of vaccine in nontraditional settings. The benefits and challenges highlighted by these physicians were similar to those of other workshop participants. Benefits included increased access and convenience, reduced cost for vaccination, and increased awareness of the importance of vaccination. Challenges included ensuring that trained staff are available to treat potential adverse reactions to vaccines, keeping effective records, protecting health-care providers from liability, preventing fragmentation of care, and removing restrictive legal regulations.

NCAI and the National Council on Aging emphasized the importance of collaboration between public and private sectors and community-based organizations. A panel of representatives from community-based organizations providing services to traditionally underserved populations presented ways in which their clients might be more adequately cared for by the health-care profession (e.g., providing culturally and linguistically appropriate materials and outreach programs). Organizations that currently provide vaccines to adults in several nontraditional settings (including pharmacies, nontraditional clinical settings, retail establishments, dental care facilities, churches, the workplace, and the home) provided examples of the benefits and challenges experienced in these programs.

Examples of Adult Immunization Programs in Nontraditional Settings

The Health Care Financing Administration's (HCFA) Horizons pilot project, a collaborative project between professional review organizations and nine historically black colleges and universities in eight southern states, was presented as an example of how the Federal government works with communities to provide vaccine in nontraditional settings. The goal of the Horizons project is to produce effective community-based interventions for increasing vaccine coverage rates among black populations. Tennessee's Horizons project has provided vaccines to adults in approximately 14 nontraditional settings, including shopping malls, senior citizen centers, nutrition sites, mobile units, grocery stores, voting sites, parks, and public housing projects.

Pharmacies in the United States are increasing their participation in vaccination activities (12). Pharmacists are functioning as a) vaccine advocates, by educating their clients about the importance of vaccines; b) vaccine facilitators, by hosting vaccine clinics at pharmacies; and c) vaccine administrators, by vaccinating their clients. The American Pharmaceutical Association and CDC's National Immunization Program have developed a training course to prepare pharmacists for active participation in immunization programs (13). Twenty-six states have statutes that permit pharmacists to administer vaccine. Accessability of pharmacists and the degree of trust between pharmacists and patients were suggested as factors that provide important opportunities for pharmacists to educate adults about the benefits of vaccines and, in some cases, administer vaccine.

Nurse practitioners, visiting nurses, and members of the National Black Nurses Association (NBNA) also are involved in immunization programs in nontraditional settings. Nurse practitioners, using mobile-community health centers, often provide care to traditionally underserved homeless and migrant workers and a large population of older adults who reside in rural or inner city areas. NBNA and the Visiting Nurses Association often staff immunization programs operating in nontraditional settings, including the workplace, pharmacies, and churches.

A representative from the American Association of Occupational Health Nurses noted that employers can be involved in workplace immunization activities on three levels: a) providing vaccines at the work site, administered by their own medical staff; b) contracting with health-care providers to administer vaccine at the work site; and/or c) including preventive care benefits (e.g., vaccinations) in health plans for employees. Employers generally are interested in increasing employee productivity; therefore, decreased employee absenteeism associated with receiving influenza vaccine should be highlighted (14). Potential barriers to workplace vaccination programs include employers being reluctant to disrupt work schedules or to offer vaccine to employees covered by health plans. Workplaces with a small number of employees might not be able to provide vaccination programs on their own but might be able to unite with other offices and provide vaccines in a centralized site within an office park.

New Settings and Incentives for Immunization Programs

Several additional nontraditional settings in which vaccines might be provided include soup kitchens, prisons, sheltered workshops for persons with disabilities, casinos, bingo halls, adult day care centers, major transit points, and polling stations on election days. Designation of mass immunization days (analogous to national immunization days for polio vaccination in endemic areas [15]) during which vaccinations are provided in several different settings was suggested. New incentive or endorsement programs that might increase the demand for vaccinations were also presented. For example, retail coupons and endorsement by sports teams were suggested as potential ways to enhance vaccine-seeking behavior among adults.

BENEFITS OF ADULT IMMUNIZATION PROGRAMS IN NONTRADITIONAL SETTINGS

Access and Convenience

The most common benefits of administering vaccine in nontraditional settings noted by workshop presenters are increased access and convenience. Providing vaccines in settings readily accessible to adults who are most in need of the services is critical. For many adults, the need to use transportation to reach a health-care provider is a barrier to receiving preventive services (7,9). This barrier might be eliminated by offering preventive services (e.g., administration of vaccines) in a neighborhood retail establishment, church, or other convenient location. Eliminating the need for making an appointment in advance and avoiding the waiting time often associated with a clinic or office visit are factors that also might increase the vaccine-seeking behavior of some adults (8,9).

Reduced Cost for Vaccinations

The reduced cost of receiving vaccines in nontraditional settings compared with traditional settings is another potential benefit. The current cost of administering influenza and pneumococcal vaccines in a nontraditional setting is $10-$15 and $15-$20, respectively. Adults without health insurance might be willing to pay for a vaccine administered in a nontraditional setting when they would be unwilling or unable to pay the greater cost associated with a physician's office visit (16,17). For adults who are covered by Medicare, HCFA has mandated reimbursement for health-care providers who administer influenza vaccine, regardless of the setting, even if the health-care provider is not a member of the vaccinee's health-care plan.

Increased Awareness for Vaccinations Among Adults

An indirect benefit of administering vaccine in nontraditional settings is increased public awareness of the need for adult immunization. This benefit is realized in two ways. First, many immunization programs operating in nontraditional settings use direct marketing to inform the community about their services and why they are important. Although marketing strategies might be directed toward promoting a specific site, the actual benefit is likely a general increase in public awareness regarding the importance and availability of vaccines for adults. Secondly, immunization programs in nontraditional settings often elicit media attention, which might increase community awareness of the need for vaccination of adults.

CHALLENGES OF ADULT IMMUNIZATION PROGRAMS IN NONTRADITIONAL SETTINGS

Adverse Reactions to Vaccines

Vaccine providers should be trained to manage adverse reactions that might occur. Concerns regarding postvaccination observation included: "Should direct observation of vaccine recipients be routine? If so, what is the duration of observation? If a severe adverse reaction occurs, are trained and skilled personnel on site to respond appropriately?"

Recordkeeping

Important factors regarding recordkeeping include how to determine which adults are in need of vaccines and how to prevent inappropriate revaccination.* Immunization registries might play a role in resolving this issue; however, most existing immunization registries do not include information regarding adults. Until immunization registries routinely include this information, the primary-care provider and/or health department should be notified when a vaccine is administered in a nontraditional setting so that patient immunization records can be updated. In addition, vaccinees should be provided with wallet-sized vaccine records. These efforts will help ensure that adults are offered appropriately timed vaccines and that their vaccination status is accessible to their health-care provider in traditional or nontraditional settings and to other health-care providers who might offer them vaccines in nontraditional settings.

Liability of Health-Care Providers

Many workshop participants considered liability protection for health-care providers an important component of any adult immunization program. Health-care providers might be more likely to promote and administer vaccines if they could be assured of not being held liable for incidents of rare but serious adverse reactions to vaccines.

Legal Regulations

Workshop participants described several restrictive legal regulations regarding the administration of vaccines. In many states, legislation restricts who can administer vaccines and under what circumstances. In some areas, new immunization programs that might reach populations at high risk for disease could be hampered by restrictive legal regulations.

Integrating Vaccine Programs in Nontraditional and Traditional Settings

One challenge of offering vaccines in a setting that does not provide other preventive services is fragmentation of care. Workshop participants acknowledged the importance of having a medical home to ensure appropriate and comprehensive preventive care, early diagnosis, and optimal therapy. Immunization programs in nontraditional settings should facilitate identification of medical homes for medically underserved adults who need a health-care provider. To promote integration of preventive care services when an adult with a regular primary-care provider is vaccinated in a nontraditional setting, the primary-care provider should be notified by the vaccine provider of the patient's vaccination status. Vaccination status is often a marker for other health-care needs. Therefore, adults seeking vaccines in nontraditional settings also might need other preventive health services (e.g., mammograms and lipid screenings). In addition, these programs need systematic procedures (e.g., providing lists of nearby physicians and offering to schedule appointments) to ensure that referrals to primary- care providers are offered when appropriate and that relevant health promotion and disease prevention literature are available on site.

Quality of Services

The mission of an immunization program and the motivation of the health-care providers who operate the program might affect the quality of services provided. Important components of quality care when administering vaccines in nontraditional settings include a) ability to handle adverse reactions, b) notification of the primary-care provider or health department when vaccines are administered, c) physician referral services, and d) providing education regarding other key preventive health measures.

FUTURE CONSIDERATIONS AND PRIORITIES

The conclusions reached by workshop participants were based primarily on expert opinion and anecdotal information. Both workshop participants and NVAC recognize the need for research targeted at providing data that addresses the effectiveness of immunization programs in nontraditional settings in reaching previously unvaccinated adults.

NVAC recommends that program evaluation be conducted to determine the impact of immunization programs in nontraditional settings on vaccine coverage rates and vaccine-preventive disease rates among adults. Specifically, the following concerns should be addressed:

  • Determine characteristics of persons receiving vaccine in nontraditional settings, including demographic characteristics, previous vaccine-seeking behavior, and previous and anticipated future use of the traditional medical system. A survey of persons using nontraditional settings for vaccination could provide these data.
  • Determine characteristics of programs successfully reaching hard-to-reach, previously unvaccinated adults. Demonstration projects, including various types of programs (e.g., those operated by service versus for-profit organizations) in different locations, including churches, work sites, and pharmacies, need to be assessed to determine which combination of features creates the most successful program.
  • Catalogue the types of services provided. The catalogue could include the following features: reporting to primary-care physician, referral to physician, provision of educational materials regarding the importance of other preventive care measures, the number of programs offering each service, and the effect of these services on program operating costs.
  • Determine if the nontraditional settings in which vaccines are administered are accessible locations and settings in which medically underserved populations feel comfortable receiving vaccine. This information could be obtained by surveying these adults.
  • Determine the potential effect of liability protection on physician practice patterns by surveying physicians.
  • Determine reasons nonphysician providers in some states are not allowed to administer vaccines in nontraditional settings. These reasons could be ad-dressed by surveying state legislators and health officials.

GUIDANCE FROM NVAC FOR CONDUCTING ADULT IMMUNIZATION PROGRAMS IN NONTRADITIONAL SETTINGS

Although no formalized, coordinated effort to provide vaccinations in nontraditional settings exists at the national level, many adults are already receiving vaccine in these settings. To ensure the safety of persons receiving vaccines in these settings, NVAC has established seven quality standards for vaccine providers conducting or planning to conduct adult immunization programs in nontraditional settings.

Quality standards for immunization programs in nontraditional settings generally coincide with the quality standards for programs in traditional settings. NVAC's quality standards for immunization programs in nontraditional settings are consistent with existing adult immunization standards of the Advisory Committee on Immunization Practices (ACIP) (20), ACP (21), the Infectious Disease Society of America (22), and NCAI (23), with additional caveats specific to nontraditional settings.

Standard 1: Information and Education for Vaccinees

Before receiving vaccine, the vaccinee must be given information about the risks and benefits associated with vaccination, including the CDC-developed Vaccination Information Statements that address the risks and benefits for 12 commonly administered vaccines, including influenza and pneumococcal vaccines. This information should be culturally and linguistically appropriate and written at a reading level that can be easily understood. The vaccine provider should be available to accurately address questions and concerns posed by the vaccinee.

Vaccinees should also be informed regarding the importance of having a medical home and receiving other preventive medical services. In addition, health promotion and disease prevention literature should be available on site and offered to the vaccinee.

Standard 2: Vaccine Storage and Handling

Adherence to vaccine handling and storage recommendations included in vaccine package inserts is critical because mishandling and inappropriate storage can render vaccines ineffective. Influenza and pneumococcal vaccines are the primary vaccines administered in nontraditional settings. These vaccines should be stored at temperatures between 2 C and 8 C (38 F and 48 F), and records of storage temperature should be maintained. Temperatures below freezing destroy the potency of these vaccines (24). Vaccine providers are responsible for ensuring appropriate storage of vaccines and should be trained accordingly. Storage procedures will become more complex if the types of vaccine offered in nontraditional settings increase.

Standard 3: Immunization History

Prevaccination screening interviews should be conducted and immunization histories of vaccinees obtained before administering vaccines. At a minimum, the following information should be obtained from the vaccinee: vaccines previously received, preexisting health conditions, allergies, and adverse events that occurred after previous vaccinations. Consulting the vaccinee's medical record is the most reliable method of determining immunization status; however, this is not always feasible, especially among adults receiving vaccines in nontraditional settings. In many cases, the medical record might not be available or, if available, might not contain the most recent information, particularly if a vaccine was not administered by the vaccinee's primary-care provider. Although repeated pneumococcal vaccination (especially within 24 months) might be associated with local adverse reactions more severe than those occurring after initial vaccination (19,25), ACIP and ACP recommend that the vaccine be offered when vaccination status cannot be determined (19,21).

Standard 4: Contraindications

Before administering vaccine, vaccine providers must assess the presence of contraindications. This assessment, part of the process of assessing the vaccinee's immunization history (Standard 3), should be made during the prevaccination screening interview. If a contraindication to immunization exists, this information should be provided to the primary-care provider or local health department and the vaccinee.

Severe systemic hypersensitivity reactions (including anaphylaxis) to egg protein, gelatin, neomycin, or streptomycin are contraindications for vaccines that contain these products (e.g., influenza vaccines). Live virus vaccines are generally contraindicated for adults who are immunocompromised and for women who are pregnant. These important contraindications affect only a small number of adults. Adults who need vaccine are more likely to not be offered it because of misconceptions concerning contraindications (see Box).

Standard 5: Recordkeeping

Each time an adult receives a dose of vaccine, the following information should be recorded: vaccinee's name, age, preexisting health conditions, type of vaccine, dose, site and route of administration, name of the vaccine provider, date vaccine was administered, manufacturer and lot number, and date that the next dose is due. If possible, this information should be recorded in the vaccinee's medical file, sent to their primary-care provider, and given to the vaccinee. Retrievable files also should be maintained by the vaccine provider in compliance with general medical practice and state requirements.

Many adults do not have a primary-care provider and, even if they do, vaccine is often not administered by their primary-care provider. Geographic and occupational mobility, changes in sources of health care, and economic factors often cause adults to see several health-care providers throughout their lifetime. As a result, vaccination records are often dispersed among a number of health-care providers. When vaccine is administered by a health-care provider other than the vaccinee's primary-care provider (e.g., vaccine received in a nontraditional setting), a vaccine card with the information noted in this standard should be provided to the primary-care provider or local health department (if no such provider can be identified) and the vaccinee. When possible, reminder notices should be sent to adults alerting them of when they are due for another vaccination.

Standard 6: Vaccine Administration

Health-care providers who administer vaccine must have the legal authority to do so and must be appropriately trained and licensed in all aspects of vaccine administration, including a) proper storage and handling of vaccines, b) information to be elicited from clients before vaccination (Standard 3), c) information to be given to clients before vaccination (Vaccine Information Statements), d) techniques for vaccine administration (20), and e) ability to handle adverse reactions.

Specific information regarding the recommended route of administration and appropriate dose is included in the package insert of each vaccine. Most vaccines are administered intramuscularly or subcutaneously. The dose indicated in the insert should be the dose administered. Administering one half of the recommended dose to potentially reduce the risk for adverse reaction has not been demonstrated to be an effective method of reducing adverse reactions and could result in inadequate protection against disease (26).

Standard 7: Adverse Events

Vaccine providers must be trained to recognize and treat adverse reactions, and the equipment needed to do so must be available on site. Vaccines are safe and effective; however, adverse events, ranging from minor, local reactions to severe systemic illness, occasionally occur following vaccination. Although severe, systemic reactions are rare, they can be life-threatening. Vaccine providers should be trained to use medications (epinephrine, atropine, and sodium bicarbonate) and conduct procedures necessary to maintain the airway and manage cardiovascular collapse (basic and advanced cardiopulmonary resuscitation [CPR], operation of a defibrillator, and use of a self- reinflating ventilating bag [Ambu bag] to provide positive pressure ventilation during resuscitation). Vaccine providers must be in close proximity to a telephone so that emergency medical personnel can be summoned immediately, if necessary.

Vaccinees should be monitored for adverse reactions after receiving vaccine. If a severe adverse reaction occurs while the vaccinee is on site or any time after receiving vaccine, the primary-care provider or local health department should be notified.

To improve knowledge about vaccines and vaccine-associated adverse reactions, all serious adverse events should be reported to the Vaccine Adverse Event Reporting System (VAERS) (21). VAERS reporting forms and assistance can be obtained by telephone (1-800-822-7967) or through the CDC Internet site at <http://www.cdc.gov/nip/vaers.htm>.

CONCLUSION

The ability of vaccines to save lives and prevent suffering extends beyond childhood. As with childhood vaccines, adult vaccines are a cost-effective means of preventing disease (27,28). To realize these benefits, vaccines must be made readily available to the public. Although rates of vaccine coverage among adults are increasing, many adults (especially among economically disadvantaged, inner city, and minority populations) are not receiving appropriate vaccinations (2). Enhancing educational efforts and increasing the number and types of programs (e.g., standing orders [29] and nontraditional settings) safely administering vaccine to adults might increase the number of adults receiving vaccines and the associated benefits. 

Educating health-care providers and the public is the cornerstone of an effective vaccination strategy. The Adult Immunization Action Plan (1) emphasizes the need for physicians and other health-care providers to recognize both the severity of influenza and pneumococcal disease and the safety and effectiveness of vaccines so they consistently offer vaccines to their patients. Physicians' recommendations influence patients' decisions to receive vaccine, regardless of the patients' initial attitude (6). However, some adults who need vaccination receive medical care but are not offered vaccine, whereas others might not have regular contact with traditional health-care settings. For these reasons, increased efforts to educate the public as well as health-care providers are needed. The 1994 NVAC report on adult immunization concluded that "better public understanding of the seriousness of vaccine-preventable diseases and the benefits of vaccination will be essential if there are to be improvements in adult immunization" (30).

An essential step toward creating an effective immunization infrastructure integrating traditional and nontraditional immunization programs is to determine the role each type of program has in the overall immunization strategy. Data from immunization programs in traditional and nontraditional settings are needed to assess who receives vaccine in which settings and why they choose that setting. Data characterizing persons who do not receive vaccine and their reasons for not getting vaccinated also are needed. These data will facilitate the development of a comprehensive immunization strategy to increase immunization coverage in all segments of the adult population.

Integration of nontraditional immunization programs with the existing health-care infrastructure provides the potential to increase vaccine coverage rates and decrease vaccine-preventable diseases among adults. To do so most effectively, the specific contributions of immunization programs in traditional and nontraditional settings need to be established, and the quality standards in this report need to be implemented. The efforts that effectively lowered vaccine-preventable disease rates among children now need to be targeted toward developing new and effective immunization programs that will make appropriate vaccines readily accessible to adults.

References

  1. CDC. Adult immunization action plan: report of the Workgroup on Adult Immunization. Atlanta, GA: US Department of Health and Human Services, CDC, 1998. Available on the Internet at <http://www.cdc.gov/od/nvpo/adult.htm>. Accessed February 22, 2000.
  2. CDC. Influenza and pneumococcal vaccination levels among adults aged >65 years -- United States. MMWR 1998;47:797-802.
  3. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Intern Med 1990;150:1401-5.
  4. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992;82:1513-6.
  5. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
  6. CDC. Adult immunization: knowledge, attitudes and practices -- DeKalb and Fulton Counties, Georgia, 1998. MMWR 1988;37:657-61.
  7. CDC. Vaccination levels among Hispanic and Non-Hispanic whites aged >65 years -- Los Angeles County, California, 1996. MMWR 1997;46:1165-8.
  8. Hinman AR. Immunizations in the United States. Pediatrics 1990;86:1064-6.
  9. Orenstein WA, Atkinson W, Mason D, Bernier RH. Barriers to vaccinating preschool children. Am J Public Health 1991;81:1057-9.
  10. Cohen RA, Bloom B, Simpson G, Parsons PE. Access to health care part 3: older adults. Vital Health Stat 10 1997;198:1-12.
  11. CDC. Vaccination coverage by race/ethnicity and poverty level among children aged 1935 months -- United States, 1996. MMWR 1997;46:963-9.
  12. Grabenstein JD. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals. Vaccine 1998;16:705-10.
  13. American Pharmaceutical Association. Pharmacy-based immunization delivery: a national certificate training program. 4th ed. Washington, DC: American Pharmaceutical Association, 1999.
  14. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Eng J Med 1995;333:889-93.
  15. World Health Organization. National Immunization Day, 1999. Available on the Internet at <http://www.who.int/gpv-polio>. Accessed February 22, 2000.
  16. Healthcare Consultants of America. 1999 Physicians fee and coding guide. Augusta, GA: Healthcare Consultants of America Inc, 1999.
  17. Medical Economics Company. Drug topics: red book, 1999. Montvale, NJ: Medical Economics Company, 1999.
  18. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(No. RR-9).
  19. CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(No. RR-8).
  20. CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunizations Practices (ACIP). MMWR 1994;43(No. RR-1).
  21. American College of Physicians Task Force on Adult Immunization and Infectious Diseases Society of America. Guide for Adult Immunization. 3rd ed. Philadelphia, PA: American College of Physicians, 1994.
  22. Gershon AA, Gardner P, Peter G, Nichols K, Orenstein W. Guidelines from the Infectious Diseases Society of America: quality standards for immunization. Clin Infect Dis 1997;25: 782-6.
  23. National Coalition for Adult Immunization. Standards for adult immunization practice, 1990. Available at <http://www.nfid.org/ncai/publications/standards>. Accessed October 6, 1999.
  24. CDC. Vaccine management: recommendations for handling and storage of selected biologicals. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, 1991.
  25. Jackson LA, Benson P, Sneller VP, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA 1999;281:243-8.
  26. CDC. Public health burden of vaccine-preventable diseases among adults: standards for adult immunization practice. MMWR 1990;39:725-9.
  27. Sisk JE, Moskowitz AJ, Whang W, et al. Cost Effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278:1333-9.
  28. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
  29. National Vaccine Advisory Committee. Adult immunization: a report of the National Vaccine Advisory Committee. Atlanta, GA: CDC, 1994.
  30. CDC. Use of standing orders programs to increase adult vaccination rates: recommendations of the Advisory Committee on Immunization Practices. MMWR 2000;49(No. RR-1):15-26.

* Influenza vaccine should not be routinely administered more than once during an influenza season (18). Revaccination with pneumococcal vaccine one time, at least 5 years after initial vaccination, is recommended for persons at highest risk for pneumococcal infection (e.g., persons who are immunocompromised or who are asplenic) and those most likely to have a rapid decline in antibody concentrations. In addition, for persons vaccinated before age 65 years, a second dose should be administered at age >65 years, provided that >5 years have elapsed since the first dose (19).

BOX. Contraindications to Immunization*

True Contraindications   
(Do Not Administer Vaccine)   

 False Contraindications
(Vaccine May be Administered)

  • Anaphylactic reaction to a vaccine.
  • Mild to moderate local reaction following a dosage of an injectable antigen.
  • Anaphylactic reaction to a vaccine  component.
  • Low-grade or moderate fever following a previous vaccine dosage.
  • Moderate or severe illness with or without fever.
  • Mild acute illness with or without fever.
  • Pregnancy.
  • Current antimicrobial therapy.
  • Compromised immune system.
  • Convalescent phase of illness.
   
  • Prematurity.
   
  • Recent exposure to an infectious disease.
   
  • History of penicillin or other nonspecific allergies or fact that relatives have such allergies.

   

  • Pregnancy of mother or household contact.

   

  • Unvaccinated household contact.
   
  • Breast-feeding.

* This table is a modified version of the National Vaccine Advisory Committee's Standards for Pediatric Immunization Practices (CDC. Standards for pediatric immunization practices: recommendations of the National Vaccine Advisory Committee. MMWR 1993;42[No. RR-5]). Please consult with CDC's National Immunization Program for updates.

Return to top.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #